PAO GRP INC/SH SH (OTCMKTS:PAOG) Acquires Cannabis Indoor Grow and Lab Company In Michigan

PAO GRP INC/SH SH (OTCMKTS:PAOG) recently announced that it has acquired a cannabis grow and processing facility located in Romulus, Michigan.

The acquisition highlights the company’s focus on medical cannabis. PAO Group’s subsidiaries grow medical cannabis in Michigan and are also trying to secure LARA’s MMFLA license that will allow the subsidiaries to cultivate, process and transport medical cannabis. Karl Riedel, the CEO of PAO Group stated that the new facility that his company is acquiring is located on multiple acres of land. It also has enough room for the company to expand or scale its capacities.

“We are very excited about the opportunity and look forward to servicing the existing wholesale client base of dispensaries and edibles companies in the state of Michigan,” stated Riedel.

Distillate as a vital part of the market

The CEO also noted that the acquisition will boost his company’s ability to offer premium quality distillate as one of the major brands in the sector. Distillate is the company’s strong suit in the cannabis industry because it is a versatile ingredient because it can be incorporated into different consumer products.

According to Riedel, THC / CBD compounds are extracted and processed through cannabis distillation and this process results in the production of refined oils that have 90% purity. These oils are then infused into various products such as topical solutions, pills, edibles, beverages, and vape pens among others.

The PAO Group CEO stated that the firm will continue to run its grow operation in Michigan courtesy of its Caregiver medical marijuana licenses following Dept. of Licensing and Regulatory Affairs’ (LARA) recent announcements. LARA will recommend that the Medical Marihuana Licensing Board (MMLB) should come up with a solution that will facilitate medical marijuana access by patients during an upcoming meeting on March 21. The goal is to allow various licensed facilities to keep sourcing their products from caregivers.

Meanwhile, Riedel also announced recently that his company appointed Andres Fernandez Chief Marketing Officer (CMO). He also praised Fernandez because the two have previously worked together in three companies and so the new CMO is ideal for the position based on his experience.


PAO Group ORD (OTCMKTS:PAOG) Expecting Increase In Revenue After Converting Affiliates Into Corporate-Owned Locations

PAO Group ORD (OTCMKTS:PAOG) recently announced that the company has converted its affiliate locations for Alternative Medicine Centers of America into corporate-owned locations for expediting growth and increasing the revenues. The physicians’ management company opened new locations in North Florida last month this year. The company wanted to expedite the opening in these locations and hence COO Arthur Hall and Vice President of Operations; Chris Will joined Robert Weber, the CEO of PAOG in Florida.

PAOG to enter major states in coming months

The company also hired new physicians for these locations so that the work should start immediately. At the time of opening, Weber stated that the company has been able to come up with multiple centers in two major states of Ohio and Florida in less than a year of its operations. According to Weber, the company is planning to further expand its base by entering the markets of new states including Arkansas, Pennsylvania, and Michigan in the coming months.

Current locations of the Alternative Medicine Centers of America include Ft. Lauderdale, Jacksonville, Toledo, Orange Park, Dayton, Sandusky, and St. Augustine. The CEO further added that the company is looking for possible locations around the Dayton Beach for its next center.

PAOG eyeing increase profit margins

While discussing the decision to change the affiliate locations into corporate-owned locations, Christopher Will stated that all the executives and Board have agreed to take full ownership of the existing as well as new affiliate locations in order to increase the overall shareholder value and profit margin. However, in the process, the company will continue to maintain the consistency in providing its services including offering the latest and advanced medicinal therapy and unparalleled quality care.

COO Art Hall said that they are opening more locations during the summer. The Jacksonville and Orange Park locations in Florida are scheduled to open in June whereas the company will open a new location near Jacksonville Beach in July this year. Hall stated, “We could not be more excited about the potential here as we are also wrapping up physician licensing for our Toledo and Dayton Ohio locations, after which point we anticipate a minimum of 25-35 patients per doctor day.”


Rising India Inc (OTCMKTS:RSII) Partners With PAO GROUP (OTCMKTS:PAOG)To Provide Cannophen™ To Patients In Ohio, Florida

Rising India Inc (OTCMRTS:RSII) announced recently that it’s partnering with PAO GROUP’s (OTCMKTS:PAOG) subsidiary, Alternative Medicine Centers of America to offer a free distribution of Cannophen™ to patients who want to stop smoking/vaping residing in Ohio, Florida. The two firms are launching a trial at all its medical clinics within Ohio and the patients will be served on a first-come-first-served basis.

The drug contains portions of THC, CBD and other specified strains of Terpenes for easier digestion and is designed as an alternative for patients who don’t want to use off-tasting tinctures and prefer fast reaction. In addition, the drug contains various beneficial elements for healing a wide range of medical conditions including treating symptoms of Parkinson and other rare conditions.

Furthermore, Cannophen™ can be used to cure people suffering from cancer particularly in alleviating the side effects of chemotherapy. Previous studies have shown that cannabinoids components found in medical cannabis help in slowing down the growth of cancerous cells in the body by blocking the creation of blood vessels that nourish tumor. Furthermore, other studies conducted on animals indicate that cannabinoids kill cancer cells while at the same time protecting the normal body cells from getting infected.

Other benefits include managing chronic pain, nausea, and other complex medical conditions. The program will commence after a week and the company has already obtained a license to distribute Cannophen™ and other RSII products in Ohio. The firm also plans to expand its services to other states once the trial is successfully implemented. Patients with chronic diseases will largely benefit from the program since they would not be required to pay for their medicines or treatment.

Meanwhile, Rising Biosciences has announced that it’s also planning to launch its RBS0238 CLINICAL PEPTIDE SERUM in the second quarter of the year. The firm will commence the production phase for Peptide Serum and it will be available in the market from April 2018. The company has also presented updates on the expansion strategy and it’s partnering with two other California producers to manufacture MMJ products.

Pin It on Pinterest